The firm is focusing on specialty chronic therapies like immunotherapy, antibody-drug conjugates, and gene therapy drugs, ...
For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarterit ...
None ...
People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This ...
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...
With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions of semaglutide are no longer allowed ...
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...
Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...
Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s ...
People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye co ...
The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...